Geron Corp
(NAS:GERN)
$
4.54
0.06 (1.34%)
Market Cap: 2.74 Bil
Enterprise Value: 2.46 Bil
PE Ratio: 0
PB Ratio: 8.90
GF Score: 35/100 - Q1 2024 Geron Corp Earnings Call TranscriptMay 02, 2024$3.95 (-3.19%)Earnings
- Q4 2023 Geron Corp Earnings Call TranscriptFeb 28, 2024$1.95 (-5.57%)Earnings
- Q3 2023 Geron Corp Earnings Call TranscriptNov 02, 2023$1.78 (-7.77%)Earnings
- Geron Corp at Robert W Baird Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 Geron Corp Earnings Call TranscriptAug 03, 2023$3.16 (-1.25%)Earnings
- Geron Corp at Goldman Sachs Healthcare Conference TranscriptJun 15, 2023
- Geron Corp Investor Event TranscriptJun 14, 2023
- Q1 2023 Geron Corp Earnings Call TranscriptMay 11, 2023$2.89 (+2.48%)Earnings
- Geron Corp at Stifel Targeted Oncology Days (Virtual) TranscriptApr 25, 2023
- Geron Corp at Needham Healthcare Conference (Virtual) TranscriptApr 20, 2023
- Q4 2022 Geron Corp Earnings Call TranscriptMar 16, 2023$2.65 (+1.15%)Earnings
- Geron Corp at B Riley Securities Oncology Conference (Virtual) TranscriptJan 18, 2023
- Geron to Discuss Top-Line Results from IMerge Phase 3 Call TranscriptJan 04, 2023
- Q3 2022 Geron Corp Earnings Call TranscriptNov 03, 2022$2.03 (-5.58%)Earnings
- Geron Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Geron Corp Earnings Call TranscriptAug 11, 2022$2.05 (-5.53%)Earnings
- Q1 2022 Geron Corp Earnings Call TranscriptMay 09, 2022$1.23 (-5.38%)Earnings
- Geron Corp at Needham Healthcare Conference (Virtual) TranscriptApr 13, 2022
- Q4 2021 Geron Corp Earnings Call TranscriptMar 10, 2022$1.1 (+1.85%)Earnings
- Geron Corp Host Virtual Investor Event Call TranscriptNov 09, 2021
- Q2 2021 Geron Corp Earnings Call TranscriptAug 16, 2021$1.2 (-1.64%)Earnings
- Geron Corp Annual Shareholders Meeting TranscriptMay 11, 2021
- Q1 2021 Geron Corp Earnings Call TranscriptMay 10, 2021$1.25 (-6.02%)Earnings
- Q4 2020 Geron Corp Earnings Call TranscriptMar 11, 2021$1.89 (+3.28%)Earnings
- Q3 2020 Geron Corp Earnings Call TranscriptNov 05, 2020$1.83 (-1.61%)Earnings
- Q2 2020 Geron Corp Earnings Call TranscriptAug 06, 2020$1.66 (-3.49%)Earnings
- Geron Corporation - Special Call TranscriptJun 17, 2020
- Geron Corp Annual Shareholders Meeting TranscriptJun 05, 2020
- Q1 2020 Geron Corp Earnings Call TranscriptMay 28, 2020$1.61 (-1.83%)Earnings
- Q4 2019 Geron Corp Earnings Call TranscriptMar 12, 2020$0.99 (-3.88%)Earnings
- Q3 2019 Geron Corp Earnings Call TranscriptNov 07, 2019$1.49 (+2.76%)Earnings
- Q2 2019 Geron Corp Earnings Call TranscriptAug 01, 2019$1.15 (-4.17%)Earnings
- Geron Corporation - Special Call TranscriptJun 25, 2019
- Geron Corp Annual Shareholders Meeting TranscriptJun 06, 2019
- Geron Corporation to Provide an Imetelstat Program Update Conference Call TranscriptMay 16, 2019
- Q4 2018 Geron Corp Earnings Call TranscriptMar 07, 2019$1.43Earnings
Geron Corp at B Riley Securities Oncology Conference (Virtual) Transcript
Jan 18, 2023 / 06:00PM GMT
Release Date Price:
$3.12
(-1.58%)
Kalpit R. Patel
B. Riley Securities, Inc., Research Division - Healthcare Research Analyst
All right. Good morning, everyone. Thank you for tuning in B. Riley's Oncology Conference. I'm Kalpit Patel, a research analyst here on the biotech team at B. Riley. Our next fireside chat is with a company called Geron, and we have the company's CEO, John Scarlett. Chip, thanks very much for joining us today.
Questions & Answers
Kalpit R. Patel
B. Riley Securities, Inc., Research Division - Healthcare Research Analyst
Maybe we can get started with you had a major clearing event with imetelstat recently in lower-risk MDS. And maybe we can just start with your overall take on hitting the primary endpoint in IMerge. Were there any surprises relative to what you've seen in the Phase II, maybe both on the positive and on the negative sides of the equation?
John A. Scarlett
Geron Corporation - Chairman of the Board, President & CEO
Yes, sure. Thanks, Kalpit. I'll answer that question in a second. First of all,
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)